Suggestions
Christian Hein
Executive Director Digital Products, Novartis Group Digital Office
Professional Background
Christian Hein is a seasoned expert with a wealth of experience in the fields of pharmaceuticals, biotechnology, and digital transformation. He is currently serving as the Executive Director of Digital Products within the Group Digital Office at Novartis, where he spearheads initiatives focused on m-health and e-health solutions aimed at improving patient outcomes and driving innovation in the healthcare sector. His extensive career has been characterized by a commitment to leveraging new technologies and strategic partnerships to foster growth and efficiency within organizations.
Before joining Novartis, Christian built a robust portfolio of expertise while working as a Consultant for Digital Health & Blockchain at Pear Advisors. He played a pivotal role in enhancing digital strategies for clients, implementing innovative digital health solutions that respond to contemporary challenges in healthcare management. Prior to this role, he held several key positions at Amgen, including the Head of EU Digital Technology Hubs, where he was instrumental in fostering a culture of innovation and collaboration across European markets.
His career at Amgen is marked by his ascent through the ranks, culminating in his role as the Business Development Lead for Europe, where he successfully identified and cultivated partnerships that significantly advanced Amgen's strategic interests in the region. In addition, his time as Head of Strategic Planning and Operations, Europe, allowed him to develop and execute long-range organizational strategies that have reinforced Amgen's competitive positioning in the pharmaceutical landscape.
Education and Achievements
Christian's academic background is a strong foundation supporting his professional achievements. He pursued Executive Education in Negotiation & Decision-Making Strategies at Columbia University's prestigious Columbia Business School, honing his skills in impactful decision-making and strategic negotiation—skills which are essential in today's fast-paced, innovation-driven industries. His scholarly journey includes a Master's in Strategic Management from HEC School of Management, where he deepened his understanding of strategic frameworks applicable to corporate success.
Further enriching his knowledge, Christian obtained a Master’s degree from ESBS and a Diplôme d'études approfondies from the University of Strasbourg. These educational experiences have provided him with a comprehensive understanding of business management nuances and strategic insights applicable to various sectors, particularly in the health and pharmaceutical industries.
Notable Achievements
Christian Hein's career is marked by numerous achievements that reflect his dedication to advancing healthcare and digital health technologies. His leadership at Novartis has positioned the organization at the forefront of digital innovations, demonstrating a deep understanding of how to harness technology to meet emerging healthcare needs. Throughout his career, he has consistently aligned new technologies with business strategies, enabling organizations to adapt to the evolving landscape of healthcare delivery.
His previous roles, such as Business Intelligence/Market Research Director at Actelion and Investment Manager at Mediport Venture in Berlin, showcase his versatility and ability to blend analytical acumen with strategic foresight. Christian’s work not only emphasizes operational excellence but also anticipates market trends and identifies innovative pathways for product and service development.
Conclusion
Christian Hein is recognized as a forward-thinking leader who combines strategic insight, a robust educational background, and extensive industry experience to effect transformative changes in healthcare. As he continues to drive initiatives that merge the spheres of pharmaceuticals and digital innovation, he remains a key figure in shaping the future of healthcare delivery through technology and innovative partnerships.